Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Serum p53 antibodies assessment may help physicians to follow-up patients with Helicobacter pylori infection.

Cioffi M, Gazzerro P, Vietri MT, Rossano F, Puca GA, Molinari AM.

Gastroenterol Clin Biol. 2000 Nov;24(11):1128-9. No abstract available.

2.

Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.

Jorge O, Cuello Carrión FD, Jorge A, Ciocca DR.

Rev Esp Enferm Dig. 2003 Feb;95(2):97-104, 89-96. English, Spanish.

PMID:
12760717
3.

Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.

Sawaya M, Yoshimura T, Shimoyama T, Munakata A, Fukuda S.

J Clin Gastroenterol. 2008 Apr;42(4):351-5. doi: 10.1097/MCG.0b013e318054493e.

PMID:
18277906
4.

Diagnostic value of culture, histology and PCR for Helicobacter pylori in the remnant stomach after surgery.

Matsukura N, Tajiri T, Kato S, Togashi A, Masuda G, Tokunaga A, Yamada N.

Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:33-8.

5.

Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.

Koizumi W, Tanabe S, Imaizumi H, Hibi K, Kida M, Ohida M, Okayasu I, Saigenji K.

Hepatogastroenterology. 2003 Jan-Feb;50(49):293-6.

PMID:
12630044
6.

Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria.

Başkan EB, Türker T, Gülten M, Tunali S.

Int J Dermatol. 2005 Dec;44(12):993-5.

PMID:
16409261
7.

Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.

Scandellari R, Allemand E, Vettore S, Plebani M, Randi ML, Fabris F.

Blood Coagul Fibrinolysis. 2009 Mar;20(2):108-13. doi: 10.1097/MBC.0b013e32832315d8.

PMID:
19786938
8.
9.

Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.

Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, Kang HM, Lee HS, Jung HC, Song IS.

J Clin Gastroenterol. 2008 May-Jun;42(5):448-54. doi: 10.1097/MCG.0b013e318046eac3.

PMID:
18344895
10.

Correlation between Helicobacter pylori infection and pulmonary Wegener's granulomacytosis activity.

Zycinska K, Wardyn KA, Zycinski Z, Smolarczyk R.

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:845-51.

PMID:
19218713
11.

[Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].

Sun LP, Gong YH, Wang L, Gong W, Yuan Y.

Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2826-30. Chinese.

PMID:
17200016
12.

Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.

Araújo-Filho I, Brandão-Neto J, Pinheiro LA, Azevedo IM, Freire FH, Medeiros AC.

Arq Gastroenterol. 2006 Oct-Dec;43(4):288-92.

13.

Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.

Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM.

Clin Gastroenterol Hepatol. 2008 Apr;6(4):409-17. doi: 10.1016/j.cgh.2007.12.044. Epub 2008 Mar 5.

PMID:
18321787
14.

[Helicobacter pylori infection in gastric cancer patients].

Ławniczak M, Starzyńska T.

Pol Merkur Lekarski. 2002 Aug;13(74):103-6. Polish.

PMID:
12420337
15.

Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.

Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289.

16.

Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.

Sun LP, Gong YH, Wang L, Gong W, Yuan Y.

J Dig Dis. 2008 Feb;9(1):20-6. doi: 10.1111/j.1443-9573.2007.00321.x.

PMID:
18251790
17.

[Helicobacter pylori CagA(+) infection in gastric cancer patients].

Ławniczak M, Starzyńska T.

Pol Merkur Lekarski. 2002 Sep;13(75):216-20. Polish.

PMID:
12474574
19.

Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia.

Barbosa J, Dinis-Ribeiro M, Guilherme M, Filipe T, Lomba-Viana R, Guimarães MA, Lopes C.

Br J Biomed Sci. 2003;60(4):175-9.

PMID:
14725331
20.

Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia.

Egi Y, Ito M, Tanaka S, Imagawa S, Takata S, Yoshihara M, Haruma K, Chayama K.

Jpn J Clin Oncol. 2007 May;37(5):365-9. Epub 2007 Jun 19.

PMID:
17578895

Supplemental Content

Support Center